Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) [clinicaltrials:NCT00144625]

Bio2RDF uri

Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) [clinicaltrials:NCT00144625]

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

http://bio2rdf.org/clinicaltrials:NCT00144625

Bio2RDF identifier

NCT00144625

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00144625

http://www.w3.org/2001/XMLSchema#string

brief summary [clinicaltrials_vocabulary:brief-summary]

This is an open-label, ...... rticipated in Study MRA318JP.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Efficacy:Percentage of patients showing 30% improvement in the JIA core set every 3M, LOBS every 3 months [clinicaltrials_resource:2f8f373e64ede38bee63ad75fb59cc39]

Efficacy:Percentage of patients showing 30% improvement in the JIA core set every 3M, LOBS every 3 months [clinicaltrials_resource:30fbf8339fb00b985fc2c922cfdaf2ab]

Efficacy:Percentage of patients showing 30% improvement in the JIA core set every 3M, LOBS every 3 months [clinicaltrials_resource:c2e060429b69a380452ddd4f07a24e7e]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Efficacy:Percentage of patients showing 30% improvement in the JIA core set every 3M, LOBS every 3 months [clinicaltrials_resource:397f491245906c1e6522a1c237b27775]

completion date [clinicaltrials_vocabulary:completion-date]

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

condition [clinicaltrials_vocabulary:condition]

Polyarticular Juvenile Idiopathic Arthritis [clinicaltrials_resource:944904ec5e0d56eb32615ec223770b12]

condition browse [clinicaltrials_vocabulary:condition-browse]

Arthritis [clinicaltrials_resource:7aa48596b52c03e2baa0c6a1655cf661]

Arthritis, Juvenile [clinicaltrials_resource:9b406aa7e73809ba86734ae2d43d4354]

condition mesh [clinicaltrials_vocabulary:condition-mesh]

Arthritis [clinicaltrials_resource:7aa48596b52c03e2baa0c6a1655cf661]

Arthritis, Juvenile [clinicaltrials_resource:9b406aa7e73809ba86734ae2d43d4354]

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00144625 [clinicaltrials_resource:5c382127dd21f5327a386886d0040a80]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2005-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

MRA(Tocilizumab) [clinicaltrials_resource:111ee026b839153b3cbc96488669d028]

is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2009-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

Chugai Pharmaceutical [clinicaltrials_resource:e2dc1e0b3bd3149580dc143e4e6c6794]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00144625

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

An Open-label, Extension, Phas ...... Participated in Study MRA318JP

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

MRA319JP

http://www.w3.org/2001/XMLSchema#string

overall official [clinicaltrials_vocabulary:overall-official]

Takahiro Kakehi [clinicaltrials_resource:c06558827c73af2e5164a4dcc33f6875]

overall status [clinicaltrials_vocabulary:overall-status]

Completed [clinicaltrials_resource:07ca5050e697392c9ed47e6453f1453f]

oversight [clinicaltrials_vocabulary:oversight]

Japan: Ministry of Health, Labor and Welfare [clinicaltrials_resource:c09e75ec0404e5c904b7b6444f4704ae]

phase [clinicaltrials_vocabulary:phase]

Phase 3 [clinicaltrials_resource:8357418e2694434468870b487644532d]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

responsible party [clinicaltrials_vocabulary:responsible-party]

Chugai Pharmaceutical, Chugai Pharmaceutical [clinicaltrials_resource:ba6731498877bfef0c26ed66779be77e]

source [clinicaltrials_vocabulary:source]

Chugai Pharmaceutical [clinicaltrials_resource:e2dc1e0b3bd3149580dc143e4e6c6794]

start date [clinicaltrials_vocabulary:start-date]

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00144625 study design [clinicaltrials_resource:b8e75b82eb50203f227accd75a59727a]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00144625

verification date [clinicaltrials_vocabulary:verification-date]

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00144625

http://www.w3.org/2001/XMLSchema#string

title

Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

label

Long-term Treatment Study of M ...... ) [clinicaltrials:NCT00144625]

@en